LOGIN
Loading...
Search Filters
Date Range
toReport Types
Condition
See all (15)
Region of the Body
Specialties
See all (15)
Emerging Treatments
OE Recommends Topics
Multimedia
Journal
Conference Series
Evidence Series
Showing 1 - 20 of 50
Oral Cannabidiol Does Not Reduce Acute Non-traumatic Low Back Pain
Med J Aust. 2021 01-May;():. 10.5694/mja2.51014
Titrated THC:CBD Improves Pain and Spasticity Compared to Placebo Over 12 Weeks for Resistant MS
Int J Neurosci. 2018 Sep 13:1-10.
Dronabinol effective in reducing neuropathic pain in multiple sclerosis after 48-week treatment
Eur Neurol. 2017;78(5-6):320-329.
Oral THC/CBD spray provides neuropathic pain control in MS patients, with mild/moderate side effects
Clin Ther. 2007 Sep;29(9):2068-79
Oral tetrahydrocannabinol (THC) does not reduce chronic abdominal pain compared to placebo
Clin Gastroenterol Hepatol. 2017 Jul;15(7):1079-1086.e4. doi: 10.1016/j.cgh.2016.09.147
Tetrahydrocannabinol similar in efficacy & safety as placebo in improving spasticity and pain in MS
Clin Ther. 2018 Sep;40(9):1467-1482. doi: 10.1016/j.clinthera.2017.01.016
Dronabinol increases pain threshold compared to placebo for functional chest pain over 4 weeks
Dis Esophagus. 2017 Feb 1;30(2):1-8. doi: 10.1111/dote.12455
Delta 9-THC has better analgesic effect compared to placebo for neuropathic pain over 8 hours
J Pain. 2016 Sep;17(9):982-1000. doi: 10.1016/j.jpain.2016.05.010
The analgesic effect of vaporized cannabis versus placebo on pain
J Pain Res. 2016 Aug 31;9:587-98. doi: 10.2147/JPR.S113138. eCollection 2016
Tetrahydrocannabinol 8mg does not demonstrate better efficacy vs diazepam for chronic pancreatitis
Br J Clin Pharmacol. 2016 Mar;81(3):525-37. doi: 10.1111/bcp.12811
Dronabinol does not cause metabolic disturbances in managing chronic neuropathy pain
Clin Ther. 2015 Oct 1;37(10):2267-74. doi: 10.1016/j.clinthera.2015.07.023
Titrated THC and CBD does not significantly improve spasticity compared to placebo over 4 weeks
J Neurol. 2015 Nov;262(11):2520-7
Inhaled THC demonstrated dose-dependent pain reduction and modest side effect 4 hours post-treatment
J Pain. 2015 Jul;16(7):616-27. doi: 10.1016/j.jpain.2015.03.008
Nabilone safe and effective in pain reduction in combination with gabapentin compared to placebo
Pain Med. 2015 Jan;16(1):149-59. doi: 10.1111/pme.12569
Efficacy of a cannabis-based oromucosal spray in managing peripheral neuropathic pain
Eur J Pain. 2014 Aug;18(7):999-1012. doi: 10.1002/j.1532-2149.2013.00445.x
Oral dronabinol and smoked cannabis have similar psychoactive effects, but peak at different times
Clin J Pain. 2014 Jun;30(6):472-8. doi: 10.1097/AJP.0000000000000022
Cannabis oralmucosal spray does not significantly improve neuropathic pain from multiple sclerosis
J Neurol. 2013 Apr;260(4):984-97. doi: 10.1007/s00415-012-6739-4
Vaporized cannabis improves pain in neuropathic pain disorders
J Pain. 2013 Feb;14(2):136-48. doi: 10.1016/j.jpain.2012.10.009
THC effective for muscle stiffness relief due to MS after 12 weeks of treatment compared to placebo
J Neurol Neurosurg Psychiatry. 2012 Nov;83(11):1125-32. doi: 10.1136/jnnp-2012-302468
Nabilone effective in reducing headache in medication overuse headach patients compared to ibuprofen
J Headache Pain. 2012 Nov;13(8):677-84. doi: 10.1007/s10194-012-0490-1
Showing 1 - 20 of 50